Summary
The effects of aldose reductase inhibition on kidney function were studied in rats with streptozotocin-induced diabetes mellitus. Diabetic rats were fed sorbinil (20 and 50 mg/kg) by daily gastric gavage and were compared with untreated diabetic rats and normal rats. The rats were under daily supervision with regard to blood glucose control, insulin administration and body weight. The aim was to promote continuous body growth and to maintain the blood glucose concentration at around 22 mmol/l without large day-to-day fluctuations. The renal functional changes observed in this well-established diabetic model closely resembled those reported in human Type 1 (insulin-dependent) diabetes mellitus. Sorbinil treatment completely prevented renal cortical sorbitol accumulation, but did not abolish kidney enlargement or the increase in ultrafiltration pressure and glomerular filtration rate. Albumin excretion was increased to the same extent in the sorbinil-treated and in the untreated diabetic rats. We conclude that increased metabolism of glucose to sorbitol does not cause the hyperfiltration in rats with streptozotocin-induced diabetes.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Sandahl Christiansen JS, Gammelgaard J, Frandsen M, Parving H-H (1981) Increased kidney size, glomerular filtration rate and renal plasma flow in short-term insulin-dependent diabetics. Diabetologia 20:451–456
Jensen PK, Sandahl Christiansen J, Steven K, Parving H-H (1981) Renal function in streptozotocin-diabetic rats. Diabetologia 21: 409–414
Seyer-Hansen K (1983) Renal hypertrophy in experimental diabetes mellitus. Kidney Int 23: 643–646
Zatz R, Dunn R, Meyer TW, Anderson S, Rennke HG, Brenner BM (1986) Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77:1925–1930
Hostetter TH, Troy JL, Brenner BM (1981) Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 19: 410–415
Hostetter TH, Rennke HG, Brenner BM (1982) The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 72:375–380
Greene DA, Lattimer SA, Sima AAF (1987) Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med 316: 599–606
Hilger HH, Klümper JD, Ullrich KJ (1958) Wasserrückresorption and Ionetransport durch die Sammelrohrzellen der Sdugetierniere. Pflügers Arch 267: 218–226
Vurek GG, Pegram SE (1966) Fluorimetric method for the determination of nanogram quantities of inulin. Anal Biochem 16:409–415
Mancini G, Carbonara AO, Heremans JF (1965) Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 2:235–254
Finegold D, Lattimer SA, Nolle S, Bernstein M, Greene DA (1983) Polyol pathway activity and myoinositol metabolism. A suggested relationship in the pathogenesis of diabetic neuropathy. Diabetes 32: 988–992
Aperia A, Haldosen L-A, Larsson L, Gustafsson J-A (1985) Ontogeny of triamnicolone-acetonide binding sites in outer cortical tissue from rat kidneys. Am J Physiol 249: F891-F897
Malone JI, Leavengood H, Peterson MJ, O'Brien MM, Page MG, Aldinger CE (1984) Red blood cell sorbitol as an indicator of polyol pathway activity. Diabetes 33: 45–49
Bank N, Lahorra MAG, Aynedjian HS, Schlondorff D (1988) Vasoregulatory hormones and the hyperfiltration of diabetes. Am J Physiol 254: F202-F209
Beyer-Mears A, Ku L, Cohen MP (1984) Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil. Diabetes 33:604–607
Bank N, Mower P, Aynedjian HS, Wilkes BM, Silverman S (1989) Sorbinil prevents glomerular hyperperfusion in diabetic rats. Am J Physiol 256: F1000-F1006
Tilton RG, Chang K, Pugliese G et al. (1989) Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors. Diabetes 37: 1258–1270
Goldfarb S, Simmons DA, Kern EFO (1986) Amelioration of glomerular hyperfiltration in acute experimental diabetes mellitus by dietary myo-inositol supplementation and aldose reductase inhibition. Trans Assoc Am Phys 99:67–72
Chang WP, Dimitriadis E, Allen T, Dunlop ME, Cooper M, Larkins RG (1991) The effect of aldose reductase inhibitors on glomerular prostaglandin production and urinary albumin excretion in experimental diabetes mellitus. Diabetologia 34:225–231
Cohen RA, MacGregor LC, Spokes KC, Silva P, Epstein FH (1990) Effect of Myo-Inositol on renal Na-K-ATPase in experimental diabetes. Metabolism 39:1026–1032
Mauer SM, Steffes MW, Azar S, Brown DM (1989) Effects of sorbinil on glomerular structure and function in long-term diabetic rats. Diabetes 38: 839–846
Daniels BS, Hostetter TH (1989) Aldose reductase inhibition and glomerular abnormalities in diabetic rats. Diabetes 38: 981–986
Pedersen MM, Christiansen JS, Mogensen CE (1991) Reduction of glomerular hyperfiltration in normoalbuminuric IDDM patients by 6 months of aldose reductase inhibition. Diabetes 40: 527–531
Craven P, DeRubertis FR (1989) Sorbinil suppresses glomerular prostaglandin production in the streptozotocin diabetic rat. Metabolism 38: 649–654
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Körner, A., Celsi, G., Eklöf, A.C. et al. Sorbinil does not prevent hyperfiltration, elevated ultrafiltration pressure and albuminuria in streptozotocin-diabetic rats. Diabetologia 35, 414–418 (1992). https://doi.org/10.1007/BF02342436
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02342436